InvestorsHub Logo
Followers 67
Posts 3747
Boards Moderated 0
Alias Born 08/30/2009

Re: None

Tuesday, 03/23/2021 5:03:47 AM

Tuesday, March 23, 2021 5:03:47 AM

Post# of 232768
I wanted to share this found on YMB by FredSavage911?.

After the AMA Covid therapeutic lecture on Wednesday failed to discuss Leronlimab I called the FDA and sent Dr. Bailey the conference moderator an email to express my disappointment. Dr. Bailey emailed me back stating she did get several questions about LL and promised to address it during the next webinar. I received a call back yesterday from a man named Steve at the FDA who said he was a clinical pharmacist. He stated he and 20 other people are in charge of receiving calls about medications for covid. They keep tally of how many calls they get about each medication and those tallies get pushed up the line to higher ups. After a 10 minute conversation he consented that it is not necessarily the most logical and reasonable medications that get approved but ones that have the loudest voices behind them. I said that was ridiculous but he said unfortunately that’s America. Truly disheartening but I feel he is unfortunately right. So with that said call the fda and politely recommend they look at leronlimab very closely. Increase the tallies and make the voice for Leronlimab the loudest in the room. FDA 1-888-463-6332
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News